BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38006573)

  • 1. CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Shamsi A; Roghani SA; Soufivand P; Pournazari M; Khoobbakht F; Bahrehmand F; Taghadosi M
    Clin Rheumatol; 2024 Jan; 43(1):137-145. PubMed ID: 38006573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of N-terminal pro-B-type natriuretic peptide and related inflammatory biomarkers on periodontal treatment outcomes in patients with periodontitis: An explorative human randomized-controlled clinical trial.
    Isola G; Tartaglia GM; Santonocito S; Polizzi A; Williams RC; Iorio-Siciliano V
    J Periodontol; 2023 Dec; 94(12):1414-1424. PubMed ID: 37433155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
    Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.
    Shamsi A; Roghani SA; Abdan Z; Soufivand P; Pournazari M; Bahrehmand F; Vafaei A; Salari N; Soroush MG; Taghadosi M
    Inflammation; 2023 Dec; 46(6):2374-2385. PubMed ID: 37542661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
    Provan SA; Angel K; Odegård S; Mowinckel P; Atar D; Kvien TK
    Arthritis Res Ther; 2008; 10(3):R70. PubMed ID: 18573197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
    Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
    Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.
    Targońska-Stępniak B; Majdan M
    Clin Rheumatol; 2011 Jan; 30(1):61-9. PubMed ID: 21110214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of hs-CRP, sVCAM-1, NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifedipine.
    Wang L; Liu ZQ; Huo YQ; Yao LJ; Wei XG; Wang YF
    Asian Pac J Trop Med; 2013 Nov; 6(11):897-901. PubMed ID: 24083587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
    Yin D; Huang J; Feng L; Feng GX; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
    Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.
    Zoli A; Bosello S; Comerci G; Galiano N; Forni A; Loperfido F; Ferraccioli GF
    Rheumatol Int; 2017 Jan; 37(1):13-19. PubMed ID: 26586235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
    Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
    Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GØ; Mikkelsen K; Agewall S
    PLoS One; 2021; 16(6):e0253793. PubMed ID: 34170978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.